| scholarly article | Q13442814 |
| P2093 | author name string | Lundwall A | |
| Lilja H | |||
| P2860 | cites work | A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein | Q40921349 |
| Purification of human urinary prokallikrein. Identification of the site of activation by the metalloproteinase thermolysin | Q41973588 | ||
| Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
| A simple and very efficient method for generating cDNA libraries | Q27860461 | ||
| Efficient isolation of genes by using antibody probes | Q27860543 | ||
| Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination | Q27860827 | ||
| Amino acid sequence of the predominant basic protein in human seminal plasma | Q28307860 | ||
| Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides | Q28586567 | ||
| RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination | Q29547816 | ||
| Nucleotide sequence of cloned cDNA for human pancreatic kallikrein | Q34161823 | ||
| N-terminal amino acid sequence of human urinary prokallikrein | Q34186269 | ||
| An interactive graphics program for comparing and aligning nucleic acid and amino acid sequences | Q35507331 | ||
| Human prostate-specific antigen: structural and functional similarity with serine proteases | Q35604260 | ||
| Isolation and partial characterization of the Drosophila alcohol dehydrogenase gene | Q36409598 | ||
| Automation of the computer handling of gel reading data produced by the shotgun method of DNA sequencing | Q36649433 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 317-322 | |
| P577 | publication date | 1987-04-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Molecular cloning of human prostate specific antigen cDNA. | |
| P478 | volume | 214 |
| Q71180108 | A comparative analysis of prostate-specific antigen gene sequence in benign and malignant prostate tissue |
| Q33320106 | A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium |
| Q28248469 | A comprehensive nomenclature for serine proteases with homology to tissue kallikreins |
| Q45882775 | A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols |
| Q39543921 | A new label technology for the detection of specific polymerase chain reaction products in a closed tube |
| Q58732160 | A novel prostate cancer immunotherapy using prostate-specific antigen peptides and skin test reagent as an adjuvant |
| Q24654651 | A novel protease homolog differentially expressed in breast and ovarian cancer |
| Q36626087 | A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. |
| Q45788353 | A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate |
| Q42843731 | A structural model for the prostate disease marker, human prostate-specific antigen |
| Q38074010 | Aberrant PSA glycosylation--a sweet predictor of prostate cancer. |
| Q39418149 | Advances in Prostate-Specific Antigen Testing |
| Q63965961 | Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen |
| Q35209855 | An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers |
| Q35147686 | Analysis of prostate-specific antigen transcripts in chimpanzees, cynomolgus monkeys, baboons, and African green monkeys. |
| Q30309352 | Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites |
| Q40637840 | Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells |
| Q30454285 | Androgen-repressed phenotype in human prostate cancer |
| Q28242953 | Androgenic Induction of Prostate-specific Antigen Gene Is Repressed by Protein-Protein Interaction between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP |
| Q41170629 | Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells |
| Q36116415 | Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA. |
| Q74250095 | Bayer Immuno 1 PSA Assay: an automated, ultrasensitive method to quantitate total PSA in serum |
| Q35123256 | Biochemical staging of prostate cancer |
| Q39452085 | Can prostate-specific antigen reverse transcriptase-polymerase chain reaction be used as a prospective test to diagnose prostate cancer? |
| Q57696972 | Carbohydrate Biomarkers |
| Q48105838 | Characterization of rhesus monkey prostate specific antigen cDNA |
| Q36900678 | Characterization of the Glycosylation Site of Human PSA Prompted by Missense Mutation using LC-MS/MS. |
| Q54559731 | Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. |
| Q24528094 | Cloning and expression of human salivary-gland kallikrein in Escherichia coli |
| Q42678563 | Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA. |
| Q28285751 | Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen |
| Q24794759 | Congruence of tissue expression profiles from Gene Expression Atlas, SAGEmap and TissueInfo databases |
| Q34284652 | Dendritic Cell‐Based Immunotherapy for Prostate Cancer |
| Q83177145 | Detection of prostate specific antigen messenger RNA from pelvic lymph node in prostate cancer |
| Q41948186 | Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling |
| Q46573404 | Dipyrrylmetheneboron difluorides as labels in two-photon excited fluorometry. Part II--Nucleic acid hybridization assays |
| Q88255485 | Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology |
| Q72798902 | Dithiothreitol effects on the viscosity and quality of human semen |
| Q39481153 | Effect of prostate biopsy on the results of the PSA RT-PCR test |
| Q28267380 | Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors |
| Q77788074 | Enzyme-linked immunosorbent assay detection of prostate-specific antigen messenger ribonucleic acid in prostate cancer |
| Q36423144 | Evolution of kallikrein-related peptidases in mammals and identification of a genetic locus encoding potential regulatory inhibitors |
| Q31123489 | Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms |
| Q41273448 | Expression of active, secreted human prostate-specific antigen by recombinant baculovirus-infected insect cells on a pilot-scale |
| Q24290690 | Full-length cDNA sequence and genomic organization of human NKX3A - alternative forms and regulation by both androgens and estrogens |
| Q36258513 | Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies |
| Q73645187 | Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer |
| Q40449789 | Genomic sequence of human prostate specific antigen (PSA). |
| Q69034491 | High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen |
| Q30828173 | Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer |
| Q81411971 | Human seminal proteinase and prostate-specific antigen are the same protein |
| Q34810177 | Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring |
| Q38348367 | Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer |
| Q34429991 | Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy |
| Q33526707 | Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms |
| Q70676510 | Identification of tissue kallikrein messenger RNA in human neutrophils |
| Q67689362 | Immunological comparison between prostate-specific antigen and ?-seminoprotein |
| Q36786512 | Immunology and immunotherapy approaches for prostate cancer. |
| Q35145709 | Immunotherapy and prostate cancer |
| Q67674957 | In Situ Hybridization of Prostate-Specific Antigen mRNA in Human Prostate |
| Q46286769 | In silico identification and Bayesian phylogenetic analysis of multiple new mammalian kallikrein gene families |
| Q71917719 | In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples |
| Q41348279 | Individual prostate-specific antigen (PSA) forms as prostate tumor markers |
| Q44667140 | Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells |
| Q41130455 | Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen |
| Q77388910 | Involvement of the C-terminal end of the prostrate-specific antigen in a conformational epitope: characterization by proteolytic degradation of monoclonal antibody-bound antigen and mass spectrometry |
| Q36590875 | Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations |
| Q72098640 | Measurement of Prostate Specific Antigen and γ-Seminoprotein Ratio: A New Means of Distinguishing Benign Prostatic Hyperplasia and Prostate Cancer |
| Q39532500 | Molecular biology of tissue kallikrein |
| Q35104809 | Molecular cloning and characterization of novel prostate antigen cDNA's |
| Q34180952 | Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. |
| Q24561757 | Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein |
| Q40400486 | Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. |
| Q41450869 | Molecular forms of serum prostate-specific antigen. The clinical value of percent free prostate-specific antigen |
| Q31044291 | Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry |
| Q67703045 | Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen |
| Q34113685 | N-glycans of human protein C inhibitor: tissue-specific expression and function |
| Q57943425 | NONPROSTATIC SOURCES OF PROSTATE-SPECIFIC ANTIGEN |
| Q28208139 | Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors |
| Q30861009 | Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein |
| Q48324042 | Nucleotide sequence of the androgen-dependent arginine esterase mRNA of canine prostate |
| Q48018300 | Percent free prostate-specific antigen: the next frontier in prostate-specific antigen testing |
| Q37268890 | Potential clinical importance of the activation peptide of prostate-specific antigen |
| Q42647148 | Preliminary studies on the isolation and characterization of predominant prostatic proteins |
| Q24298371 | Primary structure of a new actin-binding protein from human seminal plasma |
| Q72105325 | Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium |
| Q36641957 | Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate |
| Q47934907 | Prostate cancer: new therapies in the pipeline? |
| Q34292339 | Prostate-specific Antigen and Human Glandular Kallikrein: Two Kallikreins of the Human Prostate |
| Q74525318 | Prostate-specific antigen (hK3) and human prostatic glandular kallikrein (hK2) in the detection of early stage human prostate cancer |
| Q35168184 | Prostate-specific antigen and diagnosing early malignancies of the prostate |
| Q37179585 | Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression |
| Q36675822 | Prostate-specific antigen and prosttic acid phosphatase: Biomolecular and physiologic characteristics |
| Q38360200 | Prostate-specific antigen expression is regulated by an upstream enhancer |
| Q34390618 | Prostate-specific antigen kallikrein and the heart |
| Q38571586 | Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system |
| Q37573519 | Prostate-specific antigen-based screening for prostate cancer in the third millennium: useful or hype? |
| Q41450853 | Prostate-specific antigen. Its discovery and biochemical characteristics |
| Q41409455 | Prostate-specific antigen: molecular forms and the human kallikrein gene family |
| Q41450890 | Prostate-specific membrane antigen and other prostatic tumor markers on the horizon |
| Q40398268 | Prostatic specific antigen |
| Q40441715 | Proteases in prostate development, function, and pathology |
| Q50700099 | Protein products of the rat kallikrein gene family. Substrate specificities of kallikrein rK2 (tonin) and kallikrein rK9 |
| Q73875569 | Purification and characterization of prostate specific antigen from human urine |
| Q42043485 | Purification of enzymes of the kallikrein gene family (rK8 and rK9) from the rat prostate |
| Q40561669 | Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction |
| Q63965952 | Quantitative PSA RT-PCR for preoperative staging of prostate cancer |
| Q31892738 | Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes |
| Q38281731 | Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer |
| Q42508371 | Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide |
| Q34510265 | Separation methods applicable to prostate cancer diagnosis and monitoring therapy. |
| Q72083438 | Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer |
| Q35869335 | Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients |
| Q34013817 | Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen. |
| Q28243373 | Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences |
| Q36116069 | Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer |
| Q43600719 | Structural characteristics of the N-glycans of two isoforms of prostate-specific antigens purified from human seminal fluid |
| Q71692628 | Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling |
| Q40386535 | Structure, function, and regulation of the enzyme activity of prostate-specific antigen |
| Q40488406 | Systemic therapy of prostate cancer. new concepts from prostate cancer tumor biology |
| Q40750531 | The biosynthesis of prostate-specific antigen in non prostatic cell lines |
| Q28303113 | The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein |
| Q34022442 | The clinical impact of different assays for prostate specific antigen. |
| Q67707331 | The evaluation of markers of prostatic function |
| Q40449782 | The nucleotide sequence of the lacC and lacD genes of Staphylococcus aureus. |
| Q71089164 | The proportion of free to total prostate specific antigen: a method of detecting prostate carcinoma |
| Q34412912 | The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19. |
| Q34447102 | The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease. |
| Q41248987 | The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy |
| Q73840613 | Thiophilic interaction chromatography of prostate-specific antigen |
| Q63965958 | Time-resolved fluorometry in end-point and real-time PCR quantification of nucleic acids |
| Q41860731 | Trypsin-like proteolytic contamination of commercially available psa purified from human seminal fluid |
| Q41977894 | Tumor-associated antigens for specific immunotherapy of prostate cancer |
| Q24564782 | Twenty Years of PSA: From Prostate Antigen to Tumor Marker |
| Q77799067 | Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia |
| Q40847202 | Understanding artificial neural networks and exploring their potential applications for the practicing urologist |
| Q37104224 | Usefulness of Total PSA Value in Prostate Diseases Diagnosis |
| Q63966425 | Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens |
| Q39763616 | alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer |
Search more.